Annual Net Income
$36.67 M
+$17.22 M+88.53%
31 December 2023
Summary:
Core Laboratories NV annual net profit is currently $36.67 million, with the most recent change of +$17.22 million (+88.53%) on 31 December 2023. During the last 3 years, it has risen by +$134.31 million (+137.56%). CLB annual net income is now -85.76% below its all-time high of $257.49 million, reached on 31 December 2014.CLB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$11.74 M
+$2.71 M+30.04%
30 September 2024
Summary:
Core Laboratories NV quarterly net profit is currently $11.74 million, with the most recent change of +$2.71 million (+30.04%) on 30 September 2024. Over the past year, it has increased by +$2.49 million (+26.88%). CLB quarterly net income is now -82.34% below its all-time high of $66.50 million, reached on 30 September 2014.CLB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$26.20 M
+$2.49 M+10.49%
30 September 2024
Summary:
Core Laboratories NV TTM net profit is currently $26.20 million, with the most recent change of +$2.49 million (+10.49%) on 30 September 2024. Over the past year, it has dropped by -$15.03 million (-36.46%). CLB TTM net income is now -89.83% below its all-time high of $257.49 million, reached on 31 December 2014.CLB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +88.5% | +26.9% | -36.5% |
| 3 y3 years | +137.6% | +1243.8% | -14.3% |
| 5 y5 years | -53.9% | -50.5% | -73.9% |
CLB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.6% | -48.6% | +722.1% | -36.5% | +199.7% |
| 5 y | 5 years | -64.0% | +137.6% | -50.5% | +110.8% | -74.3% | +126.0% |
| alltime | all time | -85.8% | +137.6% | -82.3% | +110.8% | -89.8% | +126.0% |
Core Laboratories NV Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.74 M(+30.0%) | $26.20 M(+10.5%) |
| June 2024 | - | $9.03 M(+180.5%) | $23.71 M(-36.8%) |
| Mar 2024 | - | $3.22 M(+46.4%) | $37.52 M(+2.3%) |
| Dec 2023 | $36.67 M(+88.5%) | $2.20 M(-76.2%) | $36.67 M(-11.0%) |
| Sept 2023 | - | $9.26 M(-59.5%) | $41.23 M(+4.4%) |
| June 2023 | - | $22.85 M(+862.7%) | $39.49 M(+66.5%) |
| Mar 2023 | - | $2.37 M(-64.8%) | $23.71 M(+21.9%) |
| Dec 2022 | $19.45 M(-1.4%) | $6.75 M(-10.3%) | $19.45 M(+26.4%) |
| Sept 2022 | - | $7.52 M(+6.5%) | $15.39 M(+76.1%) |
| June 2022 | - | $7.07 M(-474.3%) | $8.74 M(-10.2%) |
| Mar 2022 | - | -$1.89 M(-170.2%) | $9.73 M(-50.7%) |
| Dec 2021 | $19.73 M(-120.2%) | $2.69 M(+207.6%) | $19.73 M(-35.5%) |
| Sept 2021 | - | $874.00 K(-89.2%) | $30.58 M(-6.4%) |
| June 2021 | - | $8.06 M(-0.6%) | $32.66 M(+72.9%) |
| Mar 2021 | - | $8.11 M(-40.1%) | $18.89 M(-119.3%) |
| Dec 2020 | -$97.64 M(-195.7%) | $13.54 M(+356.9%) | -$97.64 M(-3.2%) |
| Sept 2020 | - | $2.96 M(-151.8%) | -$100.84 M(+25.9%) |
| June 2020 | - | -$5.72 M(-94.7%) | -$80.08 M(+70.6%) |
| Mar 2020 | - | -$108.42 M(-1149.6%) | -$46.95 M(-146.0%) |
| Dec 2019 | $101.98 M(+28.2%) | $10.33 M(-56.5%) | $101.98 M(+1.5%) |
| Sept 2019 | - | $23.73 M(-13.4%) | $100.49 M(+1.3%) |
| June 2019 | - | $27.41 M(-32.3%) | $99.17 M(+2.8%) |
| Mar 2019 | - | $40.51 M(+358.5%) | $96.51 M(+21.4%) |
| Dec 2018 | $79.53 M(-4.3%) | $8.84 M(-60.6%) | $79.53 M(-13.9%) |
| Sept 2018 | - | $22.41 M(-9.5%) | $92.38 M(+1.5%) |
| June 2018 | - | $24.75 M(+5.2%) | $91.06 M(+2.3%) |
| Mar 2018 | - | $23.53 M(+8.5%) | $88.99 M(+7.1%) |
| Dec 2017 | $83.13 M(+30.1%) | $21.69 M(+2.9%) | $83.13 M(+8.1%) |
| Sept 2017 | - | $21.09 M(-7.1%) | $76.89 M(+6.0%) |
| June 2017 | - | $22.69 M(+28.5%) | $72.54 M(+9.1%) |
| Mar 2017 | - | $17.66 M(+14.2%) | $66.47 M(+4.0%) |
| Dec 2016 | $63.90 M(-44.4%) | $15.46 M(-7.6%) | $63.90 M(+0.1%) |
| Sept 2016 | - | $16.73 M(+0.6%) | $63.85 M(-20.7%) |
| June 2016 | - | $16.62 M(+10.2%) | $80.53 M(-18.3%) |
| Mar 2016 | - | $15.08 M(-2.2%) | $98.53 M(-14.2%) |
| Dec 2015 | $114.85 M(-55.4%) | $15.42 M(-53.8%) | $114.85 M(-30.7%) |
| Sept 2015 | - | $33.40 M(-3.5%) | $165.62 M(-16.7%) |
| June 2015 | - | $34.63 M(+10.3%) | $198.71 M(-12.8%) |
| Mar 2015 | - | $31.40 M(-52.6%) | $227.82 M(-11.5%) |
| Dec 2014 | $257.49 M(+6.0%) | $66.19 M(-0.5%) | $257.49 M(+0.6%) |
| Sept 2014 | - | $66.50 M(+4.3%) | $256.02 M(+1.8%) |
| June 2014 | - | $63.73 M(+4.4%) | $251.42 M(+1.6%) |
| Mar 2014 | - | $61.06 M(-5.7%) | $247.36 M(+1.9%) |
| Dec 2013 | $242.81 M(+12.4%) | $64.72 M(+4.6%) | $242.81 M(+4.3%) |
| Sept 2013 | - | $61.90 M(+3.7%) | $232.89 M(+3.3%) |
| June 2013 | - | $59.68 M(+5.6%) | $225.40 M(+3.1%) |
| Mar 2013 | - | $56.52 M(+3.1%) | $218.64 M(+1.2%) |
| Dec 2012 | $216.07 M(+17.0%) | $54.80 M(+0.7%) | $216.07 M(+0.8%) |
| Sept 2012 | - | $54.40 M(+2.8%) | $214.35 M(+4.7%) |
| June 2012 | - | $52.92 M(-1.9%) | $204.81 M(+6.5%) |
| Mar 2012 | - | $53.95 M(+1.6%) | $192.34 M(+4.1%) |
| Dec 2011 | $184.68 M(+27.4%) | $53.08 M(+18.3%) | $184.68 M(+7.7%) |
| Sept 2011 | - | $44.87 M(+10.9%) | $171.55 M(+3.8%) |
| June 2011 | - | $40.45 M(-12.6%) | $165.24 M(+3.9%) |
| Mar 2011 | - | $46.29 M(+15.9%) | $159.00 M(+9.7%) |
| Dec 2010 | $144.92 M(+27.6%) | $39.94 M(+3.6%) | $144.92 M(+12.7%) |
| Sept 2010 | - | $38.55 M(+12.7%) | $128.59 M(+6.3%) |
| June 2010 | - | $34.22 M(+6.2%) | $121.03 M(+3.8%) |
| Mar 2010 | - | $32.20 M(+36.4%) | $116.62 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $113.60 M(-13.4%) | $23.62 M(-23.8%) | $113.60 M(-4.2%) |
| Sept 2009 | - | $30.99 M(+4.0%) | $118.59 M(-6.7%) |
| June 2009 | - | $29.81 M(+2.1%) | $127.12 M(-2.0%) |
| Mar 2009 | - | $29.19 M(+2.0%) | $129.68 M(+1.9%) |
| Dec 2008 | $131.17 M(+8.3%) | $28.61 M(-27.6%) | $127.24 M(-5.2%) |
| Sept 2008 | - | $39.52 M(+22.1%) | $134.16 M(+6.3%) |
| June 2008 | - | $32.37 M(+21.0%) | $126.15 M(+2.9%) |
| Mar 2008 | - | $26.75 M(-24.7%) | $122.59 M(+1.2%) |
| Dec 2007 | $121.11 M(+46.5%) | $35.53 M(+12.7%) | $121.11 M(+9.3%) |
| Sept 2007 | - | $31.51 M(+9.4%) | $110.75 M(+9.0%) |
| June 2007 | - | $28.80 M(+14.0%) | $101.62 M(+10.7%) |
| Mar 2007 | - | $25.26 M(+0.4%) | $91.78 M(+11.0%) |
| Dec 2006 | $82.66 M(+164.8%) | $25.17 M(+12.5%) | $82.66 M(+32.8%) |
| Sept 2006 | - | $22.38 M(+18.1%) | $62.24 M(+31.5%) |
| June 2006 | - | $18.96 M(+17.4%) | $47.34 M(+22.5%) |
| Mar 2006 | - | $16.14 M(+240.0%) | $38.63 M(+23.8%) |
| Dec 2005 | $31.21 M(+154.0%) | $4.75 M(-36.6%) | $31.21 M(-12.1%) |
| Sept 2005 | - | $7.49 M(-26.9%) | $35.51 M(+0.5%) |
| June 2005 | - | $10.25 M(+17.5%) | $35.33 M(+28.2%) |
| Mar 2005 | - | $8.72 M(-3.6%) | $27.55 M(+124.2%) |
| Dec 2004 | $12.29 M(-34.3%) | $9.05 M(+23.9%) | $12.29 M(+19.9%) |
| Sept 2004 | - | $7.30 M(+195.5%) | $10.25 M(+15.9%) |
| June 2004 | - | $2.47 M(-137.8%) | $8.84 M(-19.7%) |
| Mar 2004 | - | -$6.54 M(-193.2%) | $11.01 M(-41.1%) |
| Dec 2003 | $18.70 M(-306.4%) | $7.01 M(+19.0%) | $18.70 M(+27.3%) |
| Sept 2003 | - | $5.89 M(+27.2%) | $14.69 M(+23.2%) |
| June 2003 | - | $4.63 M(+300.6%) | $11.93 M(+9.3%) |
| Mar 2003 | - | $1.16 M(-61.5%) | $10.92 M(-378.4%) |
| Dec 2002 | -$9.06 M(-143.9%) | $3.00 M(-4.1%) | -$3.92 M(-57.6%) |
| Sept 2002 | - | $3.13 M(-13.6%) | -$9.25 M(+178.2%) |
| June 2002 | - | $3.62 M(-126.5%) | -$3.33 M(-496.3%) |
| Mar 2002 | - | -$13.68 M(+488.4%) | $839.00 K(-95.9%) |
| Dec 2001 | $20.63 M(+15.7%) | -$2.33 M(-125.7%) | $20.63 M(-28.1%) |
| Sept 2001 | - | $9.06 M(+16.3%) | $28.70 M(+13.2%) |
| June 2001 | - | $7.79 M(+27.4%) | $25.36 M(+18.7%) |
| Mar 2001 | - | $6.11 M(+6.4%) | $21.37 M(+19.1%) |
| Dec 2000 | $17.83 M(+711.9%) | $5.75 M(+0.6%) | $17.94 M(+28.2%) |
| Sept 2000 | - | $5.71 M(+50.5%) | $13.99 M(+4.6%) |
| June 2000 | - | $3.80 M(+41.4%) | $13.38 M(+13.1%) |
| Mar 2000 | - | $2.69 M(+49.6%) | $11.83 M(+435.9%) |
| Dec 1999 | $2.20 M(-87.5%) | $1.80 M(-64.8%) | $2.21 M(-35.3%) |
| Sept 1999 | - | $5.10 M(+127.1%) | $3.41 M(-50.6%) |
| June 1999 | - | $2.25 M(-132.4%) | $6.91 M(-4.9%) |
| Mar 1999 | - | -$6.93 M(-331.0%) | $7.27 M(-58.5%) |
| Dec 1998 | $17.60 M(+12.8%) | $3.00 M(-65.1%) | $17.50 M(-13.8%) |
| Sept 1998 | - | $8.60 M(+230.8%) | $20.30 M(+26.1%) |
| June 1998 | - | $2.60 M(-21.2%) | $16.10 M(-4.2%) |
| Mar 1998 | - | $3.30 M(-43.1%) | $16.80 M(+7.7%) |
| Dec 1997 | $15.60 M(+105.3%) | $5.80 M(+31.8%) | $15.60 M(+32.2%) |
| Sept 1997 | - | $4.40 M(+33.3%) | $11.80 M(+24.2%) |
| June 1997 | - | $3.30 M(+57.1%) | $9.50 M(+17.3%) |
| Mar 1997 | - | $2.10 M(+5.0%) | $8.10 M(+6.6%) |
| Dec 1996 | $7.60 M(+81.0%) | $2.00 M(-4.8%) | $7.60 M(+4.1%) |
| Sept 1996 | - | $2.10 M(+10.5%) | $7.30 M(+32.7%) |
| June 1996 | - | $1.90 M(+18.8%) | $5.50 M(+17.0%) |
| Mar 1996 | - | $1.60 M(-5.9%) | $4.70 M(+11.9%) |
| Dec 1995 | $4.20 M | $1.70 M(+466.7%) | $4.20 M(+68.0%) |
| Sept 1995 | - | $300.00 K(-72.7%) | $2.50 M(+13.6%) |
| June 1995 | - | $1.10 M(0.0%) | $2.20 M(+100.0%) |
| Mar 1995 | - | $1.10 M | $1.10 M |
FAQ
- What is Core Laboratories NV annual net profit?
- What is the all time high annual net income for Core Laboratories NV?
- What is Core Laboratories NV annual net income year-on-year change?
- What is Core Laboratories NV quarterly net profit?
- What is the all time high quarterly net income for Core Laboratories NV?
- What is Core Laboratories NV quarterly net income year-on-year change?
- What is Core Laboratories NV TTM net profit?
- What is the all time high TTM net income for Core Laboratories NV?
- What is Core Laboratories NV TTM net income year-on-year change?
What is Core Laboratories NV annual net profit?
The current annual net income of CLB is $36.67 M
What is the all time high annual net income for Core Laboratories NV?
Core Laboratories NV all-time high annual net profit is $257.49 M
What is Core Laboratories NV annual net income year-on-year change?
Over the past year, CLB annual net profit has changed by +$17.22 M (+88.53%)
What is Core Laboratories NV quarterly net profit?
The current quarterly net income of CLB is $11.74 M
What is the all time high quarterly net income for Core Laboratories NV?
Core Laboratories NV all-time high quarterly net profit is $66.50 M
What is Core Laboratories NV quarterly net income year-on-year change?
Over the past year, CLB quarterly net profit has changed by +$2.49 M (+26.88%)
What is Core Laboratories NV TTM net profit?
The current TTM net income of CLB is $26.20 M
What is the all time high TTM net income for Core Laboratories NV?
Core Laboratories NV all-time high TTM net profit is $257.49 M
What is Core Laboratories NV TTM net income year-on-year change?
Over the past year, CLB TTM net profit has changed by -$15.03 M (-36.46%)